New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen
- 1 January 1986
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 134 (2) , 601-608
- https://doi.org/10.1016/s0006-291x(86)80462-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Evidence that tamoxifen is a histamine antagonistBiochemical and Biophysical Research Communications, 1985
- Antiestrogenic effect of trifluoperazine in miceBiochemical Pharmacology, 1985
- Evidence that the antiestrogen binding site is a histamine or histamine-like receptorBiochemical and Biophysical Research Communications, 1985
- A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological roleBiochemical and Biophysical Research Communications, 1984
- A diphenylmethane derivative specific for the antiestrogen binding site found in rat liver microsomesBiochemical and Biophysical Research Communications, 1984
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967